FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely to development of a medical product intended for treatment and prevention of eye diseases. A pharmaceutical antiglaucoma composition contains active substances of pilocarpine - hydrochloride and hypromellose, besides - pharmaceutical aids - disodium edetate, benzalkonium chloride, sodium chloride, boric acid and water for injections in a certain ratio.
EFFECT: invention provides prolonged contact of the medicinal substance and cornea.
3 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION OF TAFLUPROST | 2021 |
|
RU2761625C2 |
OPHTHALMIC COMPOSITIONS CONTAINING PROSTAMIDE RELEASING NITROGEN OXIDE | 2019 |
|
RU2781022C2 |
EYE DROPS | 2010 |
|
RU2431470C1 |
AXELASTIN AND STEROIDS COMBINATION | 2003 |
|
RU2361593C2 |
COMPOSITION AND METHOD OF PRODUCING EYE DROPS | 2014 |
|
RU2595837C2 |
STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE | 2014 |
|
RU2687551C2 |
CONTACT LENS CARE SOLUTION | 2020 |
|
RU2755298C1 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
EYE DROPS FOR DRY EYE SYNDROME | 2011 |
|
RU2459615C1 |
PHARMACEUTICAL PREPARATIVE FORMS OF LATRUNCULIN | 2007 |
|
RU2434633C2 |
Authors
Dates
2010-10-27—Published
2009-01-11—Filed